Light at Night and Cancer Risk

Photochemistry and Photobiology

Volumn 79, Issue 4, 2004, Pages 316-318

  Schernhammer, Eva ^a   Schulmeister, Karl ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ALCOHOL CONSUMPTION; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CIRCADIAN RHYTHM; ENVIRONMENTAL EXPOSURE; FATTY ACID METABOLISM; GEOGRAPHICAL VARIATION (SPECIES); HORMONE SENSITIVITY; LIGHT EXPOSURE; REVIEW; TUMOR GROWTH; URBAN AREA;

ANIMALS; CELL DIVISION; DARKNESS; HUMANS; LIGHT; LIGHTING; MELATONIN; NEOPLASMS; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WORK SCHEDULE TOLERANCE;

EID: 2342478579     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/SA-03-28.1     Document Type: Review

References (19)

1. Kerenyi, N. A., E. Pandula and G. M. Feuer (1990) Oncostatic effects of the pineal gland. Drug Metab. Drug Interact. 8, 313-319.
2. Stevens, R. G. and S. Davis (1996) The melatonin hypothesis: electric power and breast cancer. Environ. Health Perspect. 104, 135-140.
3. Brzezinski, A. (1997) Melatonin in humans. N. Engl. J. Med. 336, 186-195.
4. Antunes, F., L. R. Barclay, K. U. Ingold, M. King, I. Q. Norris, I. C. Scaiano and F. Xi (1999) On the antioxidant activity of melatonin. Free Radic. Biol. Med. 26, 117-128.
5. Mediavilla, M. D., S. Cos and E. J. Sanchez-Barcelo (1999) Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci. 65, 415-420.
6. Blask, D. E., L. A. Sauer, R. T. Dauchy, E. W. Holowachuk, M. S. Ruhoff and H. S. Kopff (1999) Melatonin inhibition of cancer growth in vivo involves supression of tumor fatty acid metabolism via melatonin receptor-mediated signal. Cancer Res. 59, 4693-4701.
7. Vijayalaxmi, C. R. Thomas Jr., R. J. Reiter and T. S. Herman (2002) Melatonin: from basic research to cancer treatment clinics. J. Clin. Oncol. 20, 2575-2601.
8. Matsuo, T., S. Yamaguchi, S. Mitsui, A. Emi, F. Shimoda and H. Okamura (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-259.
9. Fu, L., H. Pelicano, J. Liu, P. Huang and C. Lee (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111, 41-50.
10. Filipski, E., V. M. King, X. Li, T. G. Granda, M. C. Mormont, X. Liu, B. Claustrat, M. H. Hastings and F. Levi (2002) Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 94, 690-97.
11. Taylor, P. J. and S. J. Pocock (1972) Mortality of shift and day workers 1956-68. Br. J. Ind. Med. 29, 201-207.
12. Rafnsson, V. and H. Gunnarsdottir (1990) Mortality study of fertiliser manufacturers in Iceland. Br. J. Ind. Med. 47, 721-725.
13. Pukkala, E., H. Auvinen and G. Wahlberg (1995) Incidence of cancer among Finnish airline cabin attendants. BMJ 311, 649-652.
14. Tynes, T., M. Hannevik, A. Andersen, A. Vistnes and T. Haldorsen (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7, 197-204.
15. Rafnsson, V., H. Tulinius, J. G. Jonasson and J. Hrafnkelsson (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12, 95-101.
16. Hansen, J. (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12, 74-77.
17. Davis, S., D. K. Mirick and R. G. Stevens (2001) Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 93, 1557-1562.
18. Schernhammer, E. S., F. Laden, F. E. Speizer, W. C. Willett, D. J. Hunter, I. Kawachi and G. A. Colditz (2001) Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J. Natl. Cancer Inst. 93, 1563-1568.
19. Schernharnmer, E. S., F. Laden, F. E. Speizer, W. C. Willett, D. J. Hunter, I. Kawachi, C. S. Fuchs and G. A. Colditz (2003) Night-shift work and risk of colorectal cancer in the Nurses' Health Study. J Natl. Cancer Inst. 95(11), 825-828.